Esther Biswas-Fiss’s Return to Campus Request Summary
SUBMISSION DATE: 03/26/2021
SENT TO: Esther Biswas-Fiss 03/26/2021
Submission Number | 1483 |
---|---|
Opening Phases | Phase 3 |
Name | Esther Biswas-Fiss |
Academic Classification | Professor |
PI Email | ebiswas@udel.edu |
Emergency Contact / Phone Number | 8566258300 |
College | College of Health Sciences |
Department | MEDICAL LABORATORY SCIENCES |
Lab/Facility | BIO PHARMACEUTICAL INNOVATION |
Physical Distancing and Density Requirements | Wet bench in vitro and cell culture procedures will be conducted in the laboratory spaces (457 and 459). The physical distancing and density requirements per phase 3 guidelines will be maintained. |
Additional team members that will need access |
Senem Cevik TITLE: Graduate Student, EMAIL: ceviks@udel.ecu, CONTACT: 302 690 1281, LAB/FACILITY: BIO PHARMACEUTICAL INNOVATION, RM# 457, 459 |
Department Chair | Esther Biswas-Fiss |
Department Chair Email | ebiswas@udel.edu |
Signature | Esther Biswas-Fiss |